Skip to main content

Aspire Biopharma Holdings, Inc.

ASBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001847345

No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.

Other share classesASBPW

Q3 2022 vs. Q2 2022

How the institutions holding Aspire Biopharma Holdings, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ASBP: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders5461+7
Shares24.4M25.7M+1.34M (+5.5%)
Value$243.4M$260.8M+$17.5M (+7.2%)

New holders (11)

Institutions that held Aspire Biopharma Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ASBP in Q3 2022
InstitutionSharesValue% of portfolio
Goldman Sachs Group Inc452,924$4.59M0.00%
Shaolin Capital Management LLC250,000$2.54M0.07%
Polar Asset Management Partners Inc.175,400$1.78M0.02%
Parallax Volatility Advisers, L.P.141,828$1.44M0.03%
Aristeia Capital LLC125,000$1.27M0.02%
Atalaya Capital Management LP100,000$1.01M0.14%
Prelude Capital Management, LLC47,142$478.0K0.02%
Commonwealth of Pennsylvania Public School Empls Retrmt Sys25,000$254.0K0.00%
Bulldog Investors, LLP25,000$254.0K0.07%
Castle Creek Arbitrage, LLC20,007$203.0K0.01%
Captrust Financial Advisors11,884$121.0K0.00%

Sold out (4)

Institutions that held Aspire Biopharma Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ASBP in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
HBK Investments L P300,000$2.99M
Glenmede Trust Co NA98,774$985.0K
Eisler Capital (UK) Ltd.50,000$499.0K
Old Mission Capital LLC16,671$166.0K